Moneycontrol

You are Here : No deal on Alzheimer drug; clinical trials on: Suven Life

Friday, 11:02

News of Suven Life Sciences signing a deal on Alzheimer's drugs was doing the round. However, Venkat Jasti, CEO of the company refuted all such reports and informed that though, Phase II of clinical trials for the drug is underway, the deal is not happening right now.
MAY 24, 2017
04:24 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On